Literature DB >> 15821186

Stage of lung cancer in relation to its size: part 2. Evidence.

Juan P Wisnivesky1, David Yankelevitz, Claudia I Henschke.   

Abstract

OBJECTIVE: To assess the relationship between tumor size and disease stage at the time of diagnosis in non-small cell lung cancer.
METHODS: From the Surveillance, Epidemiology and End Results registry, we identified all cases of primary non-small cell lung cancer diagnosed prior to autopsy. Among these, we focused on 84,152 cases diagnosed in 1988 or later and documented as to tumor size and disease stage at diagnosis. The distribution of disease stage within categories of tumor size was determined.
RESULTS: The smaller the tumor was, the more likely the disease was stage I. For tumors < 15 mm in diameter, the proportion of stage I was 54%, compared with 46% for 16 to 25 mm, 34% for 26 to 35 mm, 25% for 36 to 45 mm, and 15% for cases > 45 mm, with all of these proportions being very precise.
CONCLUSIONS: Tumor size has substantial bearing on disease stage in non-small cell lung cancer.

Entities:  

Mesh:

Year:  2005        PMID: 15821186     DOI: 10.1378/chest.127.4.1136

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  21 in total

Review 1.  Lung cancer screening.

Authors:  Peter J Mazzone; Tarek Mekhail
Journal:  Curr Oncol Rep       Date:  2007-07       Impact factor: 5.075

Review 2.  Lung cancer: Biology and treatment options.

Authors:  Hassan Lemjabbar-Alaoui; Omer Ui Hassan; Yi-Wei Yang; Petra Buchanan
Journal:  Biochim Biophys Acta       Date:  2015-08-19

Review 3.  The impact of second-line agents on patients' health-related quality of life in the treatment for non-small cell lung cancer: a systematic review.

Authors:  Arijit Ganguli; Phillip Wiegand; Xin Gao; John A Carter; Marc F Botteman; Saurabh Ray
Journal:  Qual Life Res       Date:  2012-07-18       Impact factor: 4.147

Review 4.  Immunotherapy and radiation therapy for operable early stage and locally advanced non-small cell lung cancer.

Authors:  Neil K Taunk; Andreas Rimner; Melissa Culligan; Joseph S Friedberg; Julie Brahmer; Jamie Chaft
Journal:  Transl Lung Cancer Res       Date:  2017-04

5.  Lipopolysaccharide enhances mouse lung tumorigenesis: a model for inflammation-driven lung cancer.

Authors:  T Melkamu; X Qian; P Upadhyaya; M G O'Sullivan; F Kassie
Journal:  Vet Pathol       Date:  2013-02-04       Impact factor: 2.221

Review 6.  Cancer stem cells in lung cancer: Evidence and controversies.

Authors:  Muhammad Alamgeer; Craig D Peacock; William Matsui; Vinod Ganju; D Neil Watkins
Journal:  Respirology       Date:  2013-07       Impact factor: 6.424

7.  Relationship between tumor size and disease stage in non-small cell lung cancer.

Authors:  Fu Yang; Haiquan Chen; Jiaqing Xiang; Yawei Zhang; Jianhua Zhou; Hong Hu; Jie Zhang; Xiaoyang Luo
Journal:  BMC Cancer       Date:  2010-09-02       Impact factor: 4.430

8.  Upregulation of glucosamine-phosphate N-acetyltransferase 1 is a promising diagnostic and predictive indicator for poor survival in patients with lung adenocarcinoma.

Authors:  Pengyuan Zhu; Shaorui Gu; Haitao Huang; Chongjun Zhong; Zhenchuan Liu; Xin Zhang; Wenli Wang; Shiliang Xie; Kaiqin Wu; Tiancheng Lu; Yongxin Zhou
Journal:  Oncol Lett       Date:  2021-04-22       Impact factor: 2.967

9.  Targeting lung cancer stem-like cells with TRAIL gene armed oncolytic adenovirus.

Authors:  Yu Yang; Haineng Xu; Weidan Huang; Miao Ding; Jing Xiao; Dongmei Yang; Huaguang Li; Xin-Yuan Liu; Liang Chu
Journal:  J Cell Mol Med       Date:  2015-02-16       Impact factor: 5.310

10.  The assessment of the role of baseline low-dose CT scan in patients at high risk of lung cancer.

Authors:  Katarzyna Kołaczyk; Anna Walecka; Tomasz Grodzki; Jacek Alchimowicz; Andrzej Smereczyński; Radosław Kiedrowicz
Journal:  Pol J Radiol       Date:  2014-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.